Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

243.73
+3.321.38%
Pre-market: 243.72-0.00640.00%07:31 EDT
Volume:10K
Turnover:2.39M
Market Cap:481.73M
PE:- -
High:244.35
Open:240.22
Low:240.22
Close:240.41
52wk High:244.35
52wk Low:160.91
Shares:1.98M
Float Shares:1.98M
Volume Ratio:0.71
T/O Rate:0.50%
Dividend:0.95
Dividend Rate:0.39%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million

Reuters
·
47 mins ago

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
3 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
15 hours ago

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
15 hours ago

Political and General News Events from August 25

Reuters
·
Yesterday

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Yesterday

Regeneron Selects Veeva Vault CRM for Global Rollout

Reuters
·
Yesterday

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Yesterday

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Yesterday

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Yesterday

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
Yesterday

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Yesterday

Political and General News Events from August 24

Reuters
·
Aug 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
Aug 24

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24